Another covid mutation from South Africa:

I am more and more convinced that they are starting to lose on the scamdemic field, and their recent "discoveries" are just desperate attempts to pump up the fast-falling level of people's scare.

A growing number of people in the UK have not only stopped buying into this scam but have also started getting angrier at our pathetic overlords. The effect of such a desperation could be that by the end of this year we may learn that yet another Russian strain can poison us with novichok, for example.
 
I am more and more convinced that they are starting to lose on the scamdemic field, and their recent "discoveries" are just desperate attempts to pump up the fast-falling level of people's scare.

A growing number of people in the UK have not only stopped buying into this scam but have also started getting angrier at our pathetic overlords. The effect of such a desperation could be that by the end of this year we may learn that yet another Russian strain can poison us with novichok, for example.

I am sure

that the powers that be, are aware of the growing resistance from the people - but also from a juridical perspective, as the powers for justice are mounting.

I do get the impression that it creates a fever pitch among the psychopathic narcissistic players in this puppet show (and the hidden authoritarian office machinery responsible for outlining more damage control strategies - to keep the narrative going)

I am a little bit surprised that the governments and authorities have neglected basically all medical findings from so many distinguished medical professionals from all around the world.

i mean, health authorities bluntly ignore, even refuse answer most of the times.

It appears that our seeming 3D balance hangs in the juridical system - IF the judges and courts get their butts up and start doing their job ! (Laws are still in favor for justice - but for how long ?)

If not - the juridical system will be nullified, too - and that would be the final tombstone of democracy.

Or will such massive, final failure - be the very steppingstone, for us to transform ?

You know... the hard way ?
 
And so it starts: Singapore Airlines launches the "Covid-19 passport"
Passengers traveling the selected routes (Jakarta and Kuala Lumpur to Singapore) will need to take their Covid-19 tests at designated clinics in Jakarta and Kuala Lumpur, where they can be issued either a digital or paper health certificate with a QR code, the airline explained in a press release. The documents will be checked by both airport check-in staff and Singapore’s immigration authority.

The airline said that Covid-19 tests and vaccinations will be “an integral part” of air travel going forward and that the certificates were an ideal way to “validate a passenger’s health credentials.” The company hailed the new ID as a way to use digital technologies to create a “more seamless experience” for customers amid “the new normal.”

Several airlines have already eyed the technology, including Qantas Airways, which said it plans to make proof of Covid-19 vaccination mandatory for all international passengers traveling to and from Australia.

The tourist industry says mandatory vaccination will kill the sector. Well, this is what the overlords want right?

WTTC (The World Travel & Tourism Council) and the industry bodies warn against the introduction of so-called ‘health passports’ – as opposed to internationally-recognised travel passes currently being considered - which would only further delay the recovery.

Recent research from WTTC shows a staggering 174 million global Travel & Tourism jobs are now threatened.

 
In case anyone isn't aware: In Israel the ptb are now getting people habituated to the idea that they will not be able to have a normal life without a "green passport".

Whoever can't produce this proof-of-vaccination document will not be allowed entry to malls, theaters etc' and will remain subject to arbitrary 2 week isolations for being near anyone who is a covid "case".

Staying calm and patient is definitely becoming harder.
 
Interesting news from Russia:

Federation Council Speaker Valentina Matvienko (this is the third person in the power structure after the President and Prime Minister) called "COVID-passports" an idea from a dystopia.

Valentina Matvienko, at a press conference in Moscow, opposed the idea of introducing special documents for people who have antibodies to coronavirus infection.
According to her, proposals of this kind came from the "area of dystopia."
“To arrange such discrimination against citizens, to divide them into categories with different rights is unacceptable, and there is no need for it. Even if a person is ill, today he has antibodies, in a month he may not. I am a categorical opponent of this kind of documents, ”said the speaker of the upper house.
According to Matvienko, the most important in the current situation is the fact that Russia has managed to increase the volume of testing. “Here we, in my opinion, are ahead of the rest of the world, which means early detection of diseases and the adoption of appropriate adequate response measures,” she said.
The Speaker of the Federation Council also noted the need for mass vaccination, which, according to her, will allow gaining national immunity. “This is the main protection of our citizens from disease and the main thing in the fight against the pandemic,” Matvienko said.

 
And so it starts: Singapore Airlines launches the "Covid-19 passport"
Passengers traveling the selected routes (Jakarta and Kuala Lumpur to Singapore) will need to take their Covid-19 tests at designated clinics in Jakarta and Kuala Lumpur, where they can be issued either a digital or paper health certificate with a QR code, the airline explained in a press release. The documents will be checked by both airport check-in staff and Singapore’s immigration authority.
Wait..what? What is the timeframe between getting tested, given your certificate and boarding a flight? What happens if you contract a virus/get a cold/come in contact with an infected person/are infected but in the incubation period just after you get your certificate and before your flight?

It makes no sense & it’s all by design. It’s not meant to 😔
 
I'm posting this research for archiving purposes. It was first published back in February 2020 in virological.org, and it shows compelling evidence of virus engineering with implications for not only fertility issues, but also neurogenesis and immune system issues.


Response to nCoV2019 Against Backdrop of Endogenous Retroviruses


It has become clear that there is a wide spectrum of illness and individual response to infection by nCoV2019, from very mild illness to induction of a cytokine storm and death. Some of this variation may lie in the fact that human infection always occurs against the backdrop of our “virome”. This includes the expression of endogenous viruses, that comprise 8% of the human genome, as well as any recent experience with other viral agents.
The spike protein belongs to Class I of fusion.entry proteins. These are constructed of a series of structural and functional domains and motifs that may be highly conserved in localized regions. Insofar as sequence motifs of nCoV2019 show high similarity to the Class I fusion/entry proteins of endogenous viruses expressed as part of the human genome – to which we would be expected to be tolerant – response to nCoV2019 could be significantly affected.
Indeed, alignment of the endogenous elements Syn1 found on human chromosome 7, or Syn2 found on chromosome 6, or HERV-K expressed from chromosome 6, all show a number of sequence motifs with significant similarity to nCoV2019 spike protein.
The first region comprises the majority of Wuhan HR1a of S2, with the corresponding region of HERV-W (Syn1). Basically, the alignment shows that HR1a of nCoV2019 and HR1 of Syn1 are directly related to one another.

Parallel HR1a and HERVW HR1
Parallel HR1a and HERVW HR1899×151 39.1 KB


Since HR2 nCoV2019 very obviously corresponds to retroviral HR2, this leaves HR1b, the central helix of nCoV2019, as the missing element when comparing coronaviruses to the other virus families with Class I fusion/entry proteins, such as the retroviruses, filoviruses and arenaviruses.
A second region of nCoV2019 that is of unknown function is the amino terminal region of S2, that in Wuhan follows the novel RRAR furin cleavage site I first disclosed here in January. This region of nCoV2019 also convincingly aligns with both Syn2 as well as HERV-K.
Shown first is the alignment with Syn2, with an extraordinary, nearly identical hexapeptide in each.

Wuhan vs HERV FRD Syn2
Wuhan vs HERV FRD Syn2898×162 37.3 KB


Over the same region, there is also an extraordinary similarity with HERV-K.
Corona HERVK beta align

Note that identical amino acids tend to be in every other position. In a beta sheet, these would lie on one side of the sheet, rendering its stereochemistry from that aspect identical, as shown in the following figure.

Parallel beta Wuhan vs HERV-k
Parallel beta Wuhan vs HERV-k1280×720 65.9 KB


Within the boxed regions, stereochemistry is identical. Any element of the host response that has seen the one in HERV-K would be expected to respond identically to that within nCoV2019.
Given the high similarity of this peptide region in nCoV2019 to endogenous retroviral peptide sequence, one hypothesis of the purpose of this region in nCoV2019 would be as a toleragen, or, when clipped out of the protein between the two endoproteolytic sites in S, as a soluble decoy peptide.
There is another region of similarity within the receptor binding domain of nCoV2019 S1, to HERV-W, likewise expected to induce tolerance.
Wuhan vs HERVW in RBD

Finally, as we disclosed here on January 30 in the pdf uploaded for free download, there is in nCoV2019 S1 a peptide region with the critical amino acids characteristic of retroviral immunosuppressive peptides. The alignment I showed then is repeated here.
ISP INCL WUHAN

While this peptide has not been shown to actually have immunosuppressive properties, it is conserved in both nCoV2019 and RaTg1. It should be noted that one of the characteristics shown by patients with severe nCoV2019 disease is lymphpenia, indicative of an immunosuppressed state.
There are therefore a number of peptide regions in nCoV2019 having significant overlap with sequences expressed by human endogenous viruses, or derived therefrom during viral evolution. These could have significant effects on patient response to nCoV2019 infection, including both tolerance and immunosuppression.
Finally, antecedent infection with any number of human viruses can render a patient temporarily refractory to the induction of interferon and other modulators of the human non-specific or specific immune response. The virome of an individual may be a factor in understanding the wide spectrum of host response to nCoV2019 infection.
Bill Gallaher

Another, far different, scenario comes to mind. Where there is significant similarity to engogenous retroviral peptide motifs, the human host may see them as “ALTERED SELF”. That MAY be a prescription for an allergenic response, such as those that happen when haptens (e.g. penicillin) bind to host proteins. The development of reaginic antibody (IgE) responses may be elicited, or delayed type hypersensitivity from the T cell arm of the human response.
Regions that may be recognized as altered self may be deleterious is included in any vaccine formulation. There was in fact a SARS vaccine used in mice that elicited an allergic response upon challenge.
So, we already know that the fusion peptide(s) and aromatic-rich regions of coronaviruses have properties that make them potentially cytotoxic. Now we know of regions that may be reaginic.
In formulating a vaccine without allergic or cytotoxic side effects, we may have a problem here.
Bill

He is basically saying that the spike protein of the coronavirus (glycoprotein S) is homologous to some of the human endogenous retroviruses - viruses that are found in our DNA. For instance, to HERV-W in chromosome 7 which codes for syncytin 1 (syn1). This is where the fertility concerns were raised by the UK doctors because that protein has to do with the initial placenta.

The spike protein is also homologous with syncytin 2 from chromosome 6 and with HERV-K.

Here's some research which might shed a light in the post COVID symptoms that half of the infected people had manifested, the so called "long haulers" (akin to a Chronic Fatigue Syndrome).


Schizophrenia is a devastating psychiatric disorder that impacts on social functioning and quality of life, and there is accumulating evidence that inflammation is a potential pathogenic mechanism of schizophrenia. However, the mechanism of inflammation possibly occurred in schizophrenia has not been well understood. The endogenous retroviral protein syncytin-1 and inflammatory marker CRP are both abnormally expressed in schizophrenia patients. CRP is one of the markers of bacterial infection generally. Less clear is whether virus or viral protein can trigger the activation of CRP. Here, we detected a robust increase of the levels of syncytin-1 and CRP in schizophrenia patients, and displayed a positive correlation and marked consistency between expressions of syncytin-1 and CRP in schizophrenia patients. Furthermore, overexpression of syncytin-1 significantly elevated the levels of CRP, TLR3, and IL-6 in both human microglia and astrocytes. TLR3 deficiency impaired the expressions of CRP and IL-6 induced by syncytin-1. Importantly, we observed a cellular co-localization and a direct interaction between syncytin-1 and TLR3. Additionally, knockdown of IL-6 inhibited the syncytin-1-induced CRP expression. Thus, the totality of these results showed that viral protein syncytin-1 could trigger the activation of CRP, which might explain the elevated CRP in sterile inflammation and exhibit a novel mechanism for regulation of inflammation by syncytin-1 in schizophrenia.

Human endogenous retroviruses (HERVs) comprise approximately 8% of the human genome. Recent studies have considered HERVs as potential pathogenic factors. The majority of HERV genes are mutated and not capable of encoding functional proteins; regardless, some HERV genes, such as HERV-W envelope (env) glycoprotein, are known to have intact open reading frames. The HERV-W element on 7q21.2, which encodes a protein referred to as Syncytin-1, participates in human placental morphogenesis and can activate a pro-inflammatory and autoimmune cascade. Neuropsychological disorders are typically linked to inflammatory abnormalities. In this study, we review that Syncytin-1 has been increasingly involved in the development of neuropsychological disorders, such as schizophrenia and multiple sclerosis (MS). This study also presents inflammation imbalances in schizophrenia and MS. More importantly, we discuss the potential role and molecular mechanisms by which Syncytin-1 regulates inflammatory abnormalities in neuropsychological diseases. In summary, Syncytin-1 activity may represent a novel molecular pathogenic mechanism in neuropyschological diseases, such as schizophrenia and MS.
The role of human endogenous retroviruses (HERVs) in disease pathogenesis is unclear. We show that HERV-K is activated in a subpopulation of patients with sporadic amyotrophic lateral sclerosis (ALS) and that its envelope (env) protein may contribute to neurodegeneration. The virus was expressed in cortical and spinal neurons of ALS patients, but not in neurons from control healthy individuals. Expression of HERV-K or its env protein in human neurons caused retraction and beading of neurites. Transgenic animals expressing the env gene developed progressive motor dysfunction accompanied by selective loss of volume of the motor cortex, decreased synaptic activity in pyramidal neurons, dendritic spine abnormalities, nucleolar dysfunction, and DNA damage. Injury to anterior horn cells in the spinal cord was manifested by muscle atrophy and pathological changes consistent with nerve fiber denervation and reinnervation. Expression of HERV-K was regulated by TAR (trans-activation responsive) DNA binding protein 43, which binds to the long terminal repeat region of the virus. Thus, HERV-K expression within neurons of patients with ALS may contribute to neurodegeneration and disease pathogenesis.

Background: Human endogenous retroviruses (HERVs) are genomic sequences of retroviral origin which were believed to be integrated into germline chromosomes millions of years ago and account for nearly 8% of the human genome. Although mostly defective and inactive, some of the HERVs may be activated under certain physiological and pathological conditions. While no drugs are designed specifically targeting HERVs, there are a panel of antiretroviral drugs designed against the human immunodeficiency virus and approved by the Federal Drug Administration (FDA).

Results: We determined if these antiretroviral drugs may also be effective in inhibiting HERVs. We constructed a plasmid with consensus HERV-K sequence for testing the effect of antiretroviral drugs on HERV-K. We first determined the effects of nucleoside and non-nucleotide reverse transcriptase (RT) inhibitors on HERV-K by product enhanced reverse transcription assay. We found that all RT inhibitors could significantly inhibit HERV-K RT activity. To determine the effects of antiretroviral drugs on HERV-K infection and viral production, we pseudotyped HERV-K with VSV-G and used the pseudotyped HERV-K virus to infect HeLa cells. HERV-K production was measured by quantitative real time polymerase chain reaction. We found that RT inhibitors Abacavir and Zidovudine, and integrase inhibitor Raltegravir could effectively block HERV-K infection and production. However, protease inhibitors were not as effective as RT and integrase inhibitors.

Conclusions: In summary, we identified several FDA approved antiretroviral drugs that can effectively inhibit HERV-K. These antiretrovirals may open new prospects for studying HERV-K pathophysiology and potentially for exploring treatment of diseases in which HERV-K has been implicated.

Keywords: Amyotrophic lateral sclerosis; Antiretroviral; Comparative modeling; HIV; Human endogenous retrovirus-K.
Human endogenous retroviruses (HERVs) make up 8% of the human genome. The HERV type K (HERV-K) HML-2 (HK2) family contains proviruses that are the most recent entrants into the human germ line and are transcriptionally active. In HIV-1 infection and cancer, HK2 genes produce retroviral particles that appear to be infectious, yet the replication capacity of these viruses and potential pathogenicity has been difficult to ascertain. In this report, we screened the efficacy of commercially available reverse transcriptase inhibitors (RTIs) at inhibiting the enzymatic activity of HK2 RT and HK2 genomic replication. Interestingly, only one provirus, K103, was found to encode a functional RT among those examined. Several nucleoside analogue RTIs (NRTIs) blocked K103 RT activity and consistently inhibited the replication of HK2 genomes. The NRTIs zidovudine (AZT), stavudine (d4T), didanosine (ddI), and lamivudine (3TC), and the nucleotide RTI inhibitor tenofovir (TDF), show efficacy in blocking K103 RT. HIV-1-specific nonnucleoside RTIs (NNRTIs), protease inhibitors (PIs), and integrase inhibitors (IIs) did not affect HK2, except for the NNRTI etravirine (ETV). The inhibition of HK2 infectivity by NRTIs appears to take place at either the reverse transcription step of the viral genome prior to HK2 viral particle formation and/or in the infected cells. Inhibition of HK2 by these drugs will be useful in suppressing HK2 infectivity if these viruses prove to be pathogenic in cancer, neurological disorders, or other diseases associated with HK2. The present studies also elucidate a key aspect of the life cycle of HK2, specifically addressing how they do, and/or did, replicate.IMPORTANCE Endogenous retroviruses are relics of ancestral virus infections in the human genome. The most recent of these infections was caused by HK2. While HK2 often remains silent in the genome, this group of viruses is activated in HIV-1-infected and cancer cells. Recent evidence suggests that these viruses are infectious, and the potential exists for HK2 to contribute to disease. We show that HK2, and specifically the enzyme that mediates virus replication, can be inhibited by a panel of drugs that are commercially available. We show that several drugs block HK2 with different efficacies. The inhibition of HK2 replication by antiretroviral drugs appears to occur in the virus itself as well as after infection of cells. Therefore, these drugs might prove to be an effective treatment by suppressing HK2 infectivity in diseases where these viruses have been implicated, such as cancer and neurological syndromes.

Human endogenous retrovirus type K (HERV-K) proviruses are scattered throughout the human genome, but as no infectious HERV-K virus has been detected to date, the mechanism by which these viruses replicated and populated the genome remains unresolved. Here, we provide evidence that, in addition to the RNA genomes that canonical retroviruses package, modern HERV-K viruses can contain reverse-transcribed DNA (RT-DNA) genomes. Indeed, reverse transcription of genomic HERV-K RNA into the DNA form is able to occur in three distinct times and locations: (i) in the virus-producing cell prior to viral release, yielding a DNA-containing extracellular virus particle similar to the spumaviruses; (ii) within the extracellular virus particle itself, transitioning from an RNA-containing particle to a DNA-containing particle; and (iii) after entry of the RNA-containing virus into the target cell, similar to canonical retroviruses, such as murine leukemia virus and HIV. Moreover, using a resuscitated HERV-K virus construct, we show that both viruses with RNA genomes and viruses with DNA genomes are capable of infecting target cells. This high level of genomic flexibility historically could have permitted these viruses to replicate in various host cell environments, potentially assisting in their many integration events and resulting in their high prevalence in the human genome. Moreover, the ability of modern HERV-K viruses to proceed through reverse transcription and package RT-DNA genomes suggests a higher level of replication competency than was previously understood, and it may be relevant in HERV-K-associated human diseases.

Importance: Retroviral elements comprise at least 8% of the human genome. Of all the endogenous retroviruses, HERV-K viruses are the most intact and biologically active. While a modern infectious HERV-K has yet to be found, HERV-K activation has been associated with cancers, autoimmune diseases, and HIV-1 infection. Thus, determining how this virus family became such a prevalent member of our genome and what it is capable of in its current form are of the utmost importance. Here, we provide evidence that HERV-K viruses currently found in the human genome are able to proceed through reverse transcription and historically utilized a life cycle with a surprising degree of genomic flexibility in which both RNA- and DNA-containing viruses were capable of mediating infection.

The causes of multiple sclerosis and amyotrophic lateral sclerosis have long remained elusive. A new category of pathogenic components, normally dormant within human genomes, has been identified: human endogenous retroviruses (HERVs). These represent ∼8% of the human genome, and environmental factors have reproducibly been shown to trigger their expression. The resulting production of envelope (Env) proteins from HERV-W and HERV-K appears to engage pathophysiological pathways leading to the pathognomonic features of MS and ALS, respectively. Pathogenic HERV elements may thus provide a missing link in understanding these complex diseases. Moreover, their neutralization may represent a promising strategy to establish novel and more powerful therapeutic approaches.
A new appreciation of the microbiome is changing the way we perceive human health and disease. The holobiontic nature of humans is even etched into our DNA in the form of viral symbionts. Empirical evidence for the presence of endogenous retroviruses (ERVs) in the human genome and their activity in homeostatic and pathologic states has accumulated; however, no causal relationship with human disease has been established to date. In this review, we will focus on the role of endogenous retrovirus-K in neurologic disease. Specifically, we will attempt to reconcile the pathologic contribution of ERVK in disparate neurologic diseases by providing evidence as to inter-individual differences in ERVK genotypes, addressing the molecular regulation of ERVK, and provide detailed examples of ERVK-mediated processes in nervous system diseases.
Furthermore, the HIV sequence in the spike protein is related to the Gp41 which lowers your defenses:


It regulates natural immunity, deactivating interferons, decreasing function in T lymphocytes and so forth.

This research is not meant to freak out people, but to give added tools for possible mandatory vaccinations in the future - interferon, antiretrovirals, etc. Remember, a lot of us got exposed and/or sick with this virus. If they're aiming to re-engineer stuff for the vaccine, the same still applies as before. That is, it might backfire.
 
Back
Top Bottom